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In diabetes, the glomerular basement membrane
undergoes thickening and structural alterations with
loss of glomerular permselectivity properties. How-
ever, the onset of the alterations at early phases of
diabetes is unclear. Aiming to determine the func-
tional and structural alterations of the glomerular
wall in the early stages of diabetes, we have studied
the distribution of endogenous circulating albumin
and type IV collagen in the glomerular basement
membrane, using the immunocytochemical ap-
proach. The streptozotocin-injected hyperglycemic
rat was our animal model. Renal tissues were
examined after 10 days, 2, 4 and 6 months of hyper-
glycemia. Upon immunogold labelings, changes in
the glomerular permeability to endogenous albumin
were found altered as early as upon ten days of
hyperglycemia. In contrast, no structural modifica-
tions were detected at this time point. Indeed,
glomerular basement membrane thickening and an
altered type IV collagen labeling distribution were
only observed after four months of hyperglycemia,
suggesting that functional alterations take place
early in diabetes prior to any structural modifica-
tion. In order to evaluate the reversibility of the
glomerular alterations, two-month-old diabetic ani-
mals were treated with insulin. These animals
showed a significant restoring of their glomerular
permselectivity. Our results suggest a link between
glycemic levels and alteration of glomerular perme-
ability in early stages of diabetes, probably through
high levels of glycated serum proteins.
Keywords: Glomerular basement membrane, albumin, type
IV collagen, insulin, immunocytochemistry
INTRODUCTION
The glomerular wall plays an important role in
blood filtration. Its properties have been exten-
sively studied by ultrastructural approaches
using various circulating endogenous and exo-
genous markers (Farquhar et al., 1961; Graham
and Karnovsky, 1966; Caufield and Farquhar,
1974; Lalibert6 et al., 1978; Bendayan et al.,
1986). Such studies have demonstrated that
the transglomerular passage of serum proteins
and macromolecules is highly selective. Serum
albumin for example, which has a molecular
weight of 68 kDa, is normally excluded from
transglomerular transport and is not found in
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significant amounts in the urine (Bendayan
et al., 1986; Pappenheimer, 1953; Brenner et al.,
1978a; Ryan and Karnovsky, 1976). The exclusion
of this protein has been considered to be the
combined result of size restriction and electro-
static charge repulsion (Brenner et al., 1978).
However, it has been well documented that in
diabetic nephropathy, the glomerular permselec-
tivity is markedly impaired, leading to protein-
uria (Hostetter, 1986; Viberti et al., 1983). The loss
of glomerular selective permeability occurring in
a long-term diabetic condition appears to be con-
comitant with several other alterations such
as increase in glomerular filtration rate (Ditzel
and Junker, 1973; Chistiansen et al., 1981), gly-
cation of circulating proteins (Bunn et al., 1978;
Dolholfer and Weiland, 1980; McFarland et al.,
1979; Guthrow et al., 1979; Day et al., 1980) and
basement membrane components (Cohen et al.,
1980; Trueb et al., 1984; Garlick et al., 1988;
Bendayan, 1988), as well as modifications in
the structure and composition of the basement
membrane (Farquhar et al., 1959; Hirose et al.,
1982; Bendayan, 1985; Osterby,1986; Desjardins
and Bendayan, 1990; Beisswenger and Spiro,
1970; Pathasarathy and Spiro, 1982; van den
Born et al., 1995). Therefore, associating a single
ethiopathological factor to the pathogenesis of
glomerular permeability is rather difficult.
Several studies have investigated renal altera-
tions occurring early in diabetes. Renal extra-
cellular matrix gene expression in early stages of
experimental diabetes was found to be altered
with a marked increase in the mRNAs expres-
sion of c chains of type IV procollagen (Wu et al.,
1997; Fukui et al., 1992; Yang et al., 1995; Park
et al., 1997) and fl chains of laminin (Fukui et al.,
1992; Yang et al., 1995). In addition, increases in
expression of the inhibitor of metalloproteinase-
1 (Wu et al., 1997) and TGF-fl (Yang et al., 1995;
Park et al., 1997) mRNAs have also been re-
ported. In contrast, expression of heparan sulfate
proteoglycans (Fukui et al., 1992) and metallo-
proteinase-2 (Wu et al., 1997) mRNAs seems to
undergo decreases. Moriya et al.(1993) have
demonstrated that changes in the charge selec-
tive barrier of the glomerular basement mem-
brane (GBM) may occur in early stages of experi-
mental diabetes, as early as one week after
induction of diabetes. Physiological studies
have, on the other hand, shown the existence
of microalbuminuria prior to the development of
the clinically persistent proteinuria in human
diabetes (Chiarelli et al., 1997). Microalbuminur-
ia in early phases of diabetic nephropathy seems
to be due to, or is concomitant with, distur-
bances of the charge barrier of the GBM and is
followed by damages to the size restriction
barrier (Dechert et al., 1998; Viberti and Wiseman,
1986). Although streptozotocin-induced-diabetic
rats are generally used for the study of the early
phases of diabetic nephropathy, timing in the
loss of selective permeability properties of the
GBM in this experimental model has yet to be
determined. The present study was focused on
the glomerular wall, assessing its functional and
structural features rather than the overall renal
function through clearance evaluations which
include the tubular reabsorption.
Application of the post-embedding immuno-
gold method on renal tissues allows for the high-
resolution localization of endogenous albumin
within the glomerular wall. This approach was
previously applied to the investigation of glo-
merular permeability in long-term diabetic ani-
mals and carries major advantages (Bendayan
et al., 1986). Indeed, the post-embedding ap-
proach allows for the detection of serum
proteins retained in situ under physiological
steady-state conditions. This contrasts with
methods using exogenous electron-dense tracers
introduced into the circulation with adverse
effects on vascular permeability (Cotran and
Karnovsky, 1967; Simionescu, 1979; Villaschi
et al., 1986). Furthermore, due to the particulate
nature of the colloidal gold marker, morpho-
metric evaluations can be performed assessing
the passage of endogenous serum components
through vascular walls (Bendayan et al., 1986;
Ghitescu and Bendayan, 1992; Bendayan and
Rasio, 1996). In the present study, we have
investigated the distribution of endogenousGLOMERULAR PERMSELECTIVITY 21
serum albumin across the glomerular wall, as
a parameter reflecting the glomerular permse-
lectivity properties. The work was carried out
on animals at early stages of diabetes as well
as on insulin-treated diabetic animals. We estab-
lished correlations between the time points at
which glomerular functional alterations and
ultrastructural modifications appear as well as
the reversibility of these alterations upon insu-
lin treatment. Results have demonstrated that
as early as upon ten days of hyperglycemia,
albumin distribution through the glomerular
basement membrane is altered, despite the
absence of glomerular basement membrane
thickening and normal type IV collagen distri-
bution. In addition, glycemic control achieved
by insulin treatment appears to restore the
permselectivity properties of the glomerular
wall in an early phase of diabetes.
MATERIALS AND METHODS
Animals
An experimental hyperglycemic state was in-
duced in 100 g male Sprague-Dawley rats by a
single intraperitoneal injection of streptozotocin
(70mg/kg body weight) dissolved in 10 mmol/1
citrate buffer, pH 4.5. The hyperglycemic state
developed within the first 48 h after injection
and continued throughout the entire lifetime
of the animals. This was assessed by regular
measurements of glycosuria and glycemia car-
ried out using Multistix and Dextrostix reagent
strips (Miles Ames, Ontario, Canada). Levels of
circulating insulin (postprandial) were deter-
mined by radioimmunoassay (insulin RIA kit,
Chromacod, Bio Ria, Montreal, Quebec) on
blood samples collected at the end of each
experiment. Animals of the control group, which
received only the citrate buffer, remained nor-
moglycemic. Nine groups, each comprising at
least three animals, were created. Groups 1 to 4
consisted of streptozotocin-injected animals of
ten days, two, four and six months of hyper-
glycemia, respectively. Group 5 consisted of
two-month hyperglycemic animals which after-
wards were treated subcutaneously by daily
injections of human biosynthetic insulin (Eli
Lilly Co., Indianapolis, IN, USA) for one month.
The amounts of insulin ranged from 15 to 20
units/day depending on the animal and were
adjusted according to bi-weekly blood glucose
monitoring. Groups 6, 7, 8 and 9 consisted
of age-matched control animals to groups 1
to 4. At time of death, the body weight was
measured and blood samples were taken. Strep-
tozotocin-injected rats displayed high blood
glucose and low insulin levels compared to the
age-matched control animals (Tab. I). Blood
glucose levels averaged 29.4+1.0mmol/1 for
the hyperglycemic animals (groups 1 to 4) vs.
6.6+0.35mmol/1 for their age-matched con-
trols (groups 6 to 9) and 4.9+0.8mmol/1 for
the insulin-treated streptozotocin-injected ani-
mals (group 5). Levels of circulating glycated
albumin were measured by radioimmunoassay
(Exocell Inc., Philadelphia, PA). Ten days hyper-
glycemic animals display about 3.5 times more
glycated albumin than their age-matched con-
trols (1.46 4- 0.07mg/ml vs. 0.41 4- 0.02mg/ml
for the controls), while total serum albumin
did not show any significant variation (33.95 4-
0.40mg/ml vs. 36.66 4- 3.10mg/ml for the
controls). The hyperglycemic animals also dis-
played important polyuria with total urine
24h volumes of 1134-13ml (vs. 6.7+1.5ml for
the controls). Protein and albumin excretion were
of 70.8 4- 8.6 mg/24 h and 21.5 4- 6.0 mg/24 h
respectively (vs. 38.9 4- 7.0 mg/24h and 1.5 4- 0.5
mg/24 h for the controls).
Tissue Processing
The animals were anesthetized with urethane
and the kidney cortex was immediately fixed in
situ by immersion with a periodate-lysine-
paraformaldehyde solution (McLean et al., 1974).
Small tissue fragments were sampled and
maintained in the fixative for two hours at 4C.
They were th rinsed in 0.1mol/1 phosphate22 M. DOUCET et al.
TABLE Characteristics of the control and diabetic rats
Length of time
Plasma glucose Plasma insulin
Weight (g) levels(retool/i) levels(gU/ml) GBM thickness(nm)
10 days control 160 4- 2 6.9 -4- 0.61 28.0 4- 4.0 240 4- 39
diabetic 148 4- 2 26.7 4-1.2 29.0 4- 0.5 240 4-17
2 months control 405 4- 5 7.5+ 0.25 66.0 4-11.0 230 4- 23
diabetic 286 4- 26 30.7 4- 0.7 32.0 4- 3.0 222 4- 35
4 months control 566 4-17 6.0 4- 0.2 43.5 4- 7.0 220 4- 35
diabetic 290 4- 25 28.9 4-1.2 31.5 4- 7.0 260 4- 35*
6 months control 750 4- 25 6.1 4- 0.89 30.9 4- 3.3 270 4- 28
diabetic 187 4-17 31.2 4-1.2 18.5 4- 0.5 320 4- 35*
mean values+ s.e.m., n 3 5 animals; p < 0.05; p < 0.001.
buffer, dehydrated in methanol and embedded in
Lowicryl K4M at 20C as previously described
(Bendayan, 1995). Ultrathin sections were cut,
mounted on Parlodion-carbon coated nickel grids
and processed for immunocytochemistry.
Immunocytochemistry
Antigenic sites for endogenous albumin and
type IV collagen were revealed using specific
polyclonal antibodies (Cappel, West Chester,
PA, USA and Chemicon, Temecula, CA, USA,
respectively) in combination with the protein
A-gold post-embedding immunocytochemical
technique. The labeling procedure was carried
out as previously described (Bendayan, 1995).
Briefly, the grids carrying the tissue thin-sections
were incubated on a drop of 0.15 mol/1 glycine
in 0.01mol/1 phosphate buffered saline pH
7.3 (PBS) for 20 min, and transferred on a drop
of PBS containing 1% gelatin (Nanoprobes Inc,
NY, USA) for an additional 10min. Next, the
grids were incubated overnight at4C on a drop
of the anti-albumin polyclonal antibody (1:50) or
3 hours at room temperature on a drop of the
anti-type IV collagen polyclonal antibody (1:40).
After rinsing in PBS, the sections were incubat-
ed with 0.15 mol/1 glycine in PBS for 20 min and
transferred on a drop of the protein A-gold com-
plex (10 or 15nm) for a 30min incubation at
room temperature (Bendayan, 1995). The grids
were then washed with PBS, rinsed in distilled
water and dried. The tissue sections were stained
with uranyl acetate and examined with a Philips
410 electron microscope. The specificity of each
immunolabeling was assessed by various con-
trol experiments: incubation with the protein A-
gold solution alone, omitting the antibody step,
and incubation with the antibody solution to
which the corresponding antigen was added in
excess, followed by the protein A-gold complex.
Morphometric Analysis
For both antigens, the exact location of the gold
particles over the glomerular basement mem-
brane was analyzed by a morphometrical ap-
proach using an image processing system
(Videoplan 2, Carl Zeiss Inc., Toronto, Canada).
The pictures were recorded at x 16 900 and
printed to a final magnification of x 42 250. At
least fifteen pictures were analyzed for each
antigen and for each animal. The distance
between each individual gold particle and the
abluminal plasma membrane at the base of the
endothelial cells was recorded. Simultaneously,
at the same site, the distance between the base
of endothelial cell and the podocyte was also
measured. The ratio R= [distance (Endothe-
lium-gold particle)/distance (Endothelium-
Epithelium)] between these two values was
calculated. On average, 500 ratio values were
recorded for each animal and each antigen. The
distribution of these ratio values (0 <R < 1) was
determined and represented as histograms.GLOMERULAR PERMSELECTIVITY 23
Mean values were calculated and statistically
evaluated using the Mann-Whitney U test.
RESULTS
Electron microscopy examination of renal tissue
revealed the glomerular basement membrane
between the endothelial and the epithelial cells
of the glomerular wall, with its three charac-
teristic regions: the lamina lucida interna on
the subendothelial side, the lamina densa in
the central part and the lamina lucida externa
on the epithelial side (Fig. 1). Morphometrical
analysis showed that basement membrane thick-
ness of control and hyperglycemic animals at
ten days and two months is similar. In contrast,
the four-and six-month hyperglycemic animals
FIGURE Immuno-electron microscopy of endogenous albumin.
(A) Renal tissue of a two-month-old normoglycemic animal. The glomerular wall appears normal with a thin glomerular
basement membrane (GBM). The immunolabeling by gold particles, revealing albumin antigenicsites over the GBM, is mainly
located over the subendothelial side. Flocculent material present in the capillary lumen (CL) is also labeled. The urinary space
(US) as well as podocytes (P) are almost free of labeling; (B) Renal tissue of a two-month old hyperglycemic animal. The
glomerular wall shows no significant morphological changes. GBM displays a normal thickness. Gold particles are present over
the subendothelial as well as the central and subepithelial side of the GBM; (C) Renal tissue of a two-month-old streptozoto-
cin-injected insulin-treated animal. The labeling by gold particles is located mainly over the subendothelial side of the GBM.
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FIGURE 2 Morphometrical analysis of albumin distribution.
Distribution of rat albumin immunolabelings in the glomerular basement membrane of normoglycemic and streptozotocin-
injected hyperglycemic animals as expressed in ratio values R [distance (Endothelium- gold particle)/distance (Endothelium-
Epithelium)]. The histograms of all control animals (A,C,E,G) show asymmetrical distributions of the labeling, with peaks in the
region corresponding to the subendothelial side of the glomerular basement membrane. For the streptozotocin-injected
hyperglycemic animals (B,D,F,H), the distributions of the labeling appear significantly shifted to the right.GLOMERULAR PERMSELECTIVITY 25
display significant thickenings with respect to more numerous over the lamina lucida interna
the normoglycemic age-matched animals (Tab. (Fig. 1C).
I). In addition, at six months in hyperglycemic Morphometrical evaluation of the distribution
condition, the mesangial regions display large of the labelings through the GBM confirmed
accumulations of basement membrane material, these subjective observations. The ratio values
confirming previous reports (Bendayan et al., "R" between the distance of the gold particles
1986; Farquhar et al., 1959; Hirose et al., 1982; to the abluminal endothelial plasma membrane
12Isterby, 1986). and the thickness of the basement membrane
In normoglycemic animals, gold particles re- at the same site, generated on tissues from
vealing endogenous rat albumin antigenic sites normal and hyperglycemic animals, are re-
were found over the flocculent material present ported in Figure 2. In the normoglycemic
in the capillary lumina (circulating protein), as animals, a peak was systematically found at
well as over the glomerular basement mem- the level of the subendothelial side of the
brane. Labeling was almost absent in the uri- GBM (0.30 < R <0.34) (Figs. 2A, 2C, 2E, 2G). In
nary space. The labeling over the glomerular contrast, hyperglycemic animals displayed
basement membrane appeared intense over much more extended distributions with the
the subendothelial side with few particles over major peak shifting to the right towards the
the lamina densa. The lamina lucida externa subepithelial side of the GBM (R>0.4) (Figs.
on the epithelial side was almost free of label- 2B, 2D, 2F, 2H). The shifts occur as early as
ing (Fig. 1A). In tissues from hyperglycemic upon ten days of hyperglycemia and become
animals, the distribution of the labeling was more important along with the duration of
similar to that of the normoglycemic animals the hyperglycemic state. The Mann-Whitney
although the gold particles were more numer- U test demonstrated the significance of the
ous over the lamina densa and lamina lucida differences between labeling distributions from
externa (Fig. 1B). Intense labeling was also normoglycemic and hyperglycemic animals at
detected over the enlarged mesangial regions, time points as early as after ten days of hyper-
Treatment of hyperglycemic animals with insu- glycemia and thereafter (p<0.01). On the
lin appeared to reverse somehow the distribu- other hand, the labeling distribution of albumin
tion of this labeling, the gold particles being for the insulin-treated streptozotocin-injected
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FIGURE 3 Morphometrical analysis of albumin distribution.
Distribution of rat albumin immunolabeling in the glomerular basement membrane of streptozotocin-injected hyperglycemic
animals (3A) and streptozotocin-injected insulin-treated animals (3B) as expressed in ratio values (R). The histogram of the
streptozotocin-injected insulin-treated animals (3B) is similar to that of the normoglycemic animals (2C) but differs significantly
from that of the age-matched hyperglycemic animals (3A).26 M. DOUCET et al.
animals (Fig. 3B) was similar to that of the
age-matched normoglycemic animals (Fig. 2C)
and differed significantly from that of the
age-matched hyperglycemic animals (p < 0.01)
(Fig. 3A).
The ultrastructural localization of type IVcol-
lagen was also studied on tissues of two-and
four-month hyperglycemic and age-matched
control animals. Labeling by gold particles was
restricted to the extracellular matrix and was
absent from the capillary lumina, urinary space
and glomerular cells (Fig. 4). The labeling of
the glomerular basement membrane was mainly
located over the lamina densa in tissues of two-
month normoglycemic and hyperglycemic ani-
mals (Fig. 4). At four months of hyperglycemia,
the labeling was distributed mainly on the
subendothelial side of the GBM which indicates
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FIGURE 4 Immuno-electron microscopy and morphometric analysis of type IV collagen.
Immunolabelings for type IV collagen in the glomerular basement membrane of two-month normoglycemic (A) and two- (B)
and four-month (C) streptozotocin-injected hyperglycemic animals. Labeling by gold particles is concentrated on the central
lamina densa for the normoglycemic and hyperglycemic animals up to two months. In contrast, tissues from the four-month
hyperglycemic animals display significant changes with labelings located towards the subendothelial side of the GBM. The
distribution of the labeling, as expressed in ratio (R) values, reported in corresponding histograms, demonstrate significant
changes only in tissues of four-month hyperglycemic animals. (A x 39 000; B x 32 000; C x 30 000).GLOMERULAR PERMSELECTIVITY 27
an important alteration in the type IV collagen previously reported ones (Bendayan et al., 1986;
distribution. The morphometrical evaluation re- Ryan and Karnovsky, 1976). In contrast, in
ported in Figure 4 confirmed these results, hyperglycemic animals, including those at ten
The experiments performed to assess the days, albumin antigenic sites were no longer
specificity of the immunocytochemical results preferentially accumulated on the subendothe-
yield either no labeling or few gold particles lial side of the GBM, the distribution of the
over the different glomerular structures (results labeling having shifted towards the epithelial
not illustrated), side of the GBM. This indicates that the retention
of albumin by the GBM is altered in short-term
hyperglycemic condition, as it is for long-term
DISCUSSION diabetic animals (Bendayan et al., 1986). As a
matter of fact, many studies have established
In the present study, the protein A-gold im- that important alterations in the biochemical
munocytochemical technique was applied on and biophysical properties of the GBM occur in
renal tissues of normal and hyperglycemic ani- long-term diabetes and follow, or are concomi-
mals as well as of insulin-treated animals for tant with, the loss of the glomerular permselec-
assessing the passage of endogenous albumin tivity. These alterations correspond mostly to the
through the glomerular wall. In contrast to thickening of the GBM which constitutes the
the clearance studies which evaluate the over- hallmark of diabetic glomerulopathy (Osterby,
all GBM filtration and tubular reabsorption 1986; Schleicher and Olgem611er, 1992) and is
(Hardwicke and Squire, 1955), the morpho- the result of enhanced synthesis and decreased
immunocytochemical study allows for the turnover of its structural components (Cohen
evaluation of processes occurring solely at the et al., 1982). Although recent observations report-
level of the glomerular wall (Bendayan et al., ed increased expression of TGF-fl and type IV
1986; Ryan and Karnovsky, 1976). Streptozotocin- procollagen (Wu et al., 1997; Fukui et al., 1992;
injected hyperglycemic animals displayed the Yang et al., 1995; Park et al., 1997) and a decreased
typical alterations related to diabetes with expression of metalloproteinases (Wu et al.,
high blood glucose and low insulin levels with 1997; Suzuki et al., 1997) in the GBM at the early
strong proteinuria and major deficiency in phase of diabetes, the accumulation of GBM
weight gain. In addition, animals with four or components as early as upon three months of
more months of hyperglycemia displayed the diabetes is controversial (Park et al., 1997). In our
renal alterations characteristic of the diabetic study, GBM thickening was observed only after
glomerulopathy with thickening of glomerular four months of hyperglycemia. Along with this
basement membrane and enlargement of thickening, changes in the distribution of type
mesangial matrix (Hostetter, 1986; Farquhar IV collagen were also observed after four months
etal.,1959;Osterby, 1986). of hyperglycemia as in long-term diabetes
In the normoglycemic animals of all ages, (Bendayan, 1985; Osterby, 1986; Desjardins and
albumin antigenic sites were detected in capil- Bendayan, 1990; Inoue and Bendayan, 1995).
lary lumina and in the GBM mainly on its These structural alterations thus appear long
subendothelial side, few being located to the after changes in glomerular permselectivity to
epithelial side. This suggests that in normal albumin which occur as early as upon ten days
condition, albumin is mainly retained by the of hyperglycemia, indicating that the onset
GBM preventing its passage from blood to the of morphological changes does not correlate
urinary space. This result is in agreement with with the early loss of GBM selective filtration28 M. DOUCET et al.
properties. The possibility that such early alter-
ations could in principle be attributed to a direct
nephrotoxic action of streptozotocin can be
ruled out since the alterations of the glomerular
wall observed in the hyperglycemic animals
are fully restored by the insulin treatment.
Loss of glomerular filtration properties in
early diabetes could be explained by other fac-
tors or combination of factors. Heparan sulfate
proteoglycans (HSPG), through their anionic
charges, play important roles in the filtration
properties of the GBM (Pathasarathy and Spiro,
1982; van den Born et al., 1995). Decrease syn-
thesis of glomerular HSPG was previously
found in early (Moriya et al., 1993; Rohrbabach
et al., 1983) as well as late (Kanwar et al., 1983)
stages ofexperimental diabetes. Therefore, charge
barrier alterations could explain the early loss
of permselectivity properties of the GBM
(Moriya et al., 1993). On the other hand, phy-
siological factors such as the glomerular plasma
flow and filtration rates also affect glomerular
function (Hostetter et al., 1981; Anderson and
Brenner, 1988), but their real contribution to
the loss of glomerular permselectivity in early
stages of diabetes remains, however, uncertain
(Castellino et al., 1990).
Recent studies indicate that alterations in
vascular permeability during diabetes could
be due to glycation of serum proteins (Williams
et al., 1981; Wieland, 1983; Sampietro et al.,
1987; Daniels and Hausser, 1992; Sabbatini
et al., 1992; Londoo et al., 1995; Bendayan and
Londoo, 1996; Cohen and Ziyadeh, 1994).
Amadori products are the predominant forms
of circulating glycated proteins in diabetic
subjects (Ziyadeh and Cohen, 1993). Their for-
mation is rapid (Day et al., 1980; Cohen and
Ziyadeh, 1994; Higgins and Bunn, 1981) and
their half-life short (Shima et al., 1991). There-
fore, levels of Amadori products in serum are
directly related to the ambient glucose and
are significantly enhanced in diabetic condi-
tions (Neuman et al., 1994; Bakala et al., 1995).
In vitro (Williams et al., 1981; Ghiggeri et al.,
1984; Shaklai et al., 1984) and in vivo (Sampietro
et al., 1987; Sabbatini et al., 1992; Ghiggeri et al.,
1984; Layton and Jerums, 1988) studies have
demonstrated that Amadori products increase
vascular permeability. Along the same line,
in vitro studies on isolatect glomerular base-
ment membranes suggest that the sieving coef-
ficient for glycated albumin is greater than that
for the native one (Daniels and Hausser, 1992).
Recent studies have also shown that glycated
albumin injected into the circulation of normal
animals easily crosses the glomerular wall and
increases the filtration of non-glycated albumin
(Londoo et al., 1995; Bendayan and Londoo,
1996). Alteration of albumin conformation as
well as particular interactions with GBM com-
ponents have been proposed to explain this
enhanced glomerular passage of native albumin
(Londoo et al., 1995; Ghiggeri et al., 1984;
Layton and Jerums, 1988).
Our present results also show that the altered
glomerular albumin distribution in two-month
hyperglycemic animals is restored when blood
glucose levels are normalized by insulin treat-
ment. This supports the assumption that insulin
treatment can restore permselective properties
of the GBM. Since Amadori adducts formation is
directly related to blood glucose levels (Neuman
et al., 1994), we can assume that insulin treat-
ment, by reducing blood glucose levels, de-
creases concentrations of circulating Amadori
products, thus restoring glomerular function. In
conclusion, we propose that circulating glycated
albumin, already present as early as upon ten
days of hyperglycemia, could enhance glomer-
ular permeability at very early stages and could
potentially lead to glomerular injuries.
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